September 9, 2024 07:14 PM EDT
China
Manufacturing
Law

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

Zachary Brennan

Senior Editor

The US House of Rep­re­sen­ta­tives on Mon­day evening passed the Biose­cure Act with broad bi­par­ti­san sup­port, ad­vanc­ing a con­tro­ver­sial bill that could up­end many drug­mak­ers’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck­'s Eli­av Barr on sub­cu­ta­neous Keytru­da, Sum­mit and deal shop­ping

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Boehringer plans NDA fil­ing for pul­monary fi­bro­sis drug fol­low­ing Phase 3 da­ta

FDA tells on­col­o­gy com­pa­nies how to run mul­ti-re­gion­al can­cer tri­als with a US ap­proval in mind

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times